Results 231 to 240 of about 11,167,014 (325)

Acute humoral rejection and C4d immunostaining in ABO blood type‐incompatible liver transplantation

open access: yesLiver transplantation, 2006
H. Haga   +9 more
semanticscholar   +1 more source

Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1637-1646, December 2026.
ABSTRACT Background Higher von Willebrand factor (VWF) levels and lower ADAMTS13 activity are linked to increased risk of atherosclerotic cardiovascular disease, but their association with atherosclerosis burden, a potential underlying mechanism, remains unclear.
Mitra Nekouei Shahraki   +4 more
wiley   +1 more source

How I Investigate Bleeding Disorders of Unknown Cause: Current Diagnostic Pathways and Gaps in Laboratory Investigation

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 6, Page 1289-1297, December 2026.
ABSTRACT Bleeding disorder of unknown cause (BDUC) constitutes the largest group of patients presenting with a mild‐to‐moderate bleeding tendency in tertiary care settings. Their clinical bleeding phenotype is characterized by mucocutaneous bleeding, as well as bleeding following surgical challenges or childbirth, and is associated with impaired health‐
Dino Mehic   +3 more
wiley   +1 more source

Polymer‐Modulated Fructose Dehydrogenase Bioelectrocatalysis on Highly Porous Gold Electrodes for Direct Electron Transfer Fructose Sensing in Fermentation Broth

open access: yesChemElectroChem, Volume 13, Issue 22, 17 November 2026.
Highly porous gold electrodes are coupled with polymer interlayers to control fructose dehydrogenase orientation and direct electron transfer. Poly(acrylic acid) provides the most effective interface, enabling low‐potential fructose oxidation, micromolar detection, and exceptional long‐term stability in fermentation broth.
Verdiana Marchianò   +11 more
wiley   +1 more source

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

open access: yesAmerican Journal of Hematology, Volume 101, Issue 11, Page 2827-2835, November 2026.
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer   +38 more
wiley   +1 more source

ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis.

open access: yesChest, 2014
J. Reilly   +13 more
semanticscholar   +1 more source

Quinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
A series of title compounds was synthesized, with 6e and 6k exhibiting the lowest IC50 values against MCF‐7, HeLa, and HepG2 cancer cell lines. Molecular docking and dynamics revealed strong binding to the adenosine A1 receptor (ΔG = –9.02 and –9.24 kcal/mol).
Bangar Reddy Vancha   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy